IP heads into Q1 earnings release with falling profit estimates, weak demand signals and a mixed segment outlook despite DS ...

MCHP reports fiscal Q4 earnings on May 7, guiding sales of $1.26B and earnings of 48-52 cents per share as backlog, mix ...

OptimizeRx nears Q1 earnings amid declining revenue forecasts, softer trends and a cautious outlook, raising questions on near-term upside.

After the CopyFail vulnerability gave root access from any user on almost all distributions last week, this week we’ve got DirtyFrag. This chains the vulnerability in CopyFail (xfrm-ESP) and ...

Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2026. Recent ...

Interparfums, Inc. IPAR is likely to witness a bottom-line decline when it reports first-quarter 2026 earnings on May 5. The ...

ROKU heads into Q1 earnings with robust revenue growth and strong platform momentum, but device weakness and a premium ...

The restaurant industry’s top line in first-quarter 2026 likely benefited from steady consumer demand for convenience-driven ...

A new guide from Wunderkind explores why identity is critical to travel and hospitality marketing, from direct bookings to ...

The injury bug is prevalent throughout professional tennis, but it has hit the British team particularly hard at this year’s Mutua Madrid Open. The Brits only have two players, one woman and one man, ...

Cytek Biosciences, Inc. ('Cytek Biosciences” or 'Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the first quarter 2026 after market close on Thursday, May 7, 2026.